ILLRW
Triller Group Inc. SEC filings
Every EDGAR filing for Triller Group Inc. (ILLRW), newest first, with AI summaries and stories.
- Ticker
- ILLRW
- CIK
- 1769624
- Latest filing
- Sep 29
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEPRE 14ATriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE NOTABLE10-QTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-K/ATriller Group Inc.ILLRWLIVE ROUTINE144Triller Group Inc.ILLRWLIVE Brian Chung Yau Chan, planned sale of ILLRW shares
Brian Chung Yau Chan, reporting
ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINEDEFA14ATriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINEARSTriller Group Inc.ILLRWLIVE ROUTINEDEF 14ATriller Group Inc.ILLRWLIVE ROUTINERWTriller Group Inc.ILLRWLIVE NOTABLE10-QTriller Group Inc.ILLRWLIVE ROUTINE144Triller Group Inc.ILLRWLIVE Brian Chung Yau Chan, planned sale of ILLRW shares
Brian Chung Yau Chan, reporting
ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE NOTABLE10-KTriller Group Inc.ILLRWLIVE ROUTINE10-Q/ATriller Group Inc.ILLRWLIVE NOTABLENT 10-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE10-Q/ATriller Group Inc.ILLRWLIVE ROUTINE10-Q/ATriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE NOTABLE10-QTriller Group Inc.ILLRWLIVE NOTABLE10-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE ROUTINE8-KTriller Group Inc.ILLRWLIVE MAJOR8-KTriller Group Inc.ILLRWLIVE Triller Group Inc. reported: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- Item 9.01. Financial Statements and Exhibits.